Novartis Vaccines and Diagnostics Inc vs Wyeth et al, No. 2:08-cv-00067 (E.D. Tex. Apr. 26, 2011)
From the Opinion
The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.
Plaintiff Novartis Vaccines and Diagnostics, Inc. (“Novartis”) filed suit against Defendants Wyeth and Wyeth Pharmaceuticals, Inc. (collectively “Wyeth”) for patent infringement of U.S. Patent No. 6,228,620 ( “the „620 Patent”). Novartis has recently withdrawn its claim for patent infringement of U.S. Patent No. 6,060,447. This Memorandum Opinion and Order outlines the Court‟s claim construction for the four disputed terms in the „620 Patent. I.
Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error